Our study identified RBM15B as a new oncogenic molecule in HCC and proved that the YY1-RBM15B-TRAM2 signaling pathway might be a new mechanism regulating the occurrence and progression of HCC. The gene discussed is TRAM2; the disease is hepatocellular carcinoma.